
Cydekin 100mg Capsule
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Palbociclib (100mg)
Overview Cydekin 100mg Capsule
Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with the 100mg Cydekin capsule, administered concurrently with hormonal anti-cancer agents. For optimal absorption, ingest this medication with food at the same time daily, as prescribed by your physician. Dosage and frequency are determined individually and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; discontinue use only under your doctor's guidance. Common side effects include nausea, fatigue, alopecia, skin rashes, and gastrointestinal upset. Cydekin may suppress blood cell production, increasing infection risk; report any signs of infection (fever, chills, weakness, bleeding, or bruising) to your doctor immediately. Dizziness may occur; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives. Potential drug interactions exist; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout the treatment period.
Uses of Cydekin 100mg Capsule
Malignant breast tumor
Major Benefits of Cydekin 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 100mg Cydekin capsule with food.
Common Side effects of Cydekin 100mg Capsule:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Cydekin 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Cydekin 100mg Capsules with food.
How Cydekin 100mg Capsule works:
Palbociclib 100mg capsules are an anticancer agent. Its mechanism involves blocking cyclin-dependent kinases 4 and 6, crucial proteins driving cell growth and proliferation within cancerous pathways. This inhibition halts the progression of the cancer cell cycle, effectively slowing tumor development. The drug also specifically targets estrogen receptor-positive breast cancers by interfering with their cell cycle regulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Cydekin 100mg Capsule and alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Employing Cydekin 100mg capsules during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might consider prescription if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Lactation is contraindicated with Cydekin 100mg capsules due to potential infant toxicity. Evidence indicates the medication may harm a nursing infant.
DrivingUNSAFE
Using Cydekin 100mg capsules might lead to adverse reactions impacting driving capabilities. Some individuals experience tiredness. Therefore, cautious operation of vehicles or machinery is advised if this occurs.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate dosage modification for Cydekin 100mg capsules; their use in such patients is considered safe.
LiverCAUTION
Patients with liver impairment should use Cydekin 100mg Capsules cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Cydekin 100mg Capsule :
NA
Facts to Know About Cydekin 100mg Capsule
| Label | Value |
|---|---|
| Chemical Classification | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | CDK Inhibitor |
